tiprankstipranks
Trending News
More News >
Bicycle Therapeutics Reports Q1 2025 Progress and Financials
PremiumCompany AnnouncementsBicycle Therapeutics Reports Q1 2025 Progress and Financials
2M ago
Bicycle Therapeutics price target lowered to $15 from $40 at Barclays
Premium
The Fly
Bicycle Therapeutics price target lowered to $15 from $40 at Barclays
2M ago
Bicycle Therapeutics: Promising Advancements and Strong Financial Position Justify Buy Rating
Premium
Ratings
Bicycle Therapeutics: Promising Advancements and Strong Financial Position Justify Buy Rating
2M ago
Bicycle Therapeutics: Buy Rating Backed by Promising Clinical Developments and Strategic Positioning
PremiumRatingsBicycle Therapeutics: Buy Rating Backed by Promising Clinical Developments and Strategic Positioning
3M ago
Bicycle Therapeutics Announces Key Leadership Changes
Premium
Company Announcements
Bicycle Therapeutics Announces Key Leadership Changes
3M ago
Bicycle names Pierre Legault chairman, Eric Westin chief medical officer
Premium
The Fly
Bicycle names Pierre Legault chairman, Eric Westin chief medical officer
3M ago
Bicycle Therapeutics: Undervalued Stock with Promising Pipeline and Innovative Platform
PremiumRatingsBicycle Therapeutics: Undervalued Stock with Promising Pipeline and Innovative Platform
4M ago
Promising Outlook for Bicycle Therapeutics: Strong Clinical Progress and Financial Health Justify Buy Rating
Premium
Ratings
Promising Outlook for Bicycle Therapeutics: Strong Clinical Progress and Financial Health Justify Buy Rating
4M ago
Bicycle Therapeutics: Promising Clinical Advances and Strong Financial Position Support Buy Rating
Premium
Ratings
Bicycle Therapeutics: Promising Clinical Advances and Strong Financial Position Support Buy Rating
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100